- Moody's•17 hours agoJazz Financing I Ltd. -- Moody's: Xyrem Patent Loss Is Credit Negative, but Other Patents Still Exist; Ratings Unaffected
New York, July 29, 2016-- New York, July 28, 2016-- Moody's Investors Service commented that Jazz Securities Limited's' s invalided patents is credit negative. However, there are other patents protecting ...
- Capital Cube•yesterdayJazz Pharmaceuticals Plc breached its 50 day moving average in a Bullish Manner : JAZZ-US : July 29, 2016
Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Jazz Pharmaceuticals Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving […]
Jazz Pharmaceuticals Public Limited CompanyNasdaqGS
After hours: 151.480.51 (0.34%) as of 4:24 PM EDT
|Bid||145.12 x 300|
|Ask||159.11 x 200|
|52wk Range||108.50 - 194.64|
|Day's Range||149.45 - 153.73|
|Avg Vol (3m)||866,793|
As of 4:00 PM EDT. Market closed.